Chemours (CC) is scheduled to report Q1 earnings on May 5, 2026. Analysts estimate EPS of $-0.05 and quarterly revenue of $1.38B.
In the most recent quarter (Q4), Chemours reported EPS of $0.05, beating estimates of $0.02 by 1.50%. Revenue came in at $1.30B, missing the estimate of $1.33B by 0.02%.
Over the last 4 quarters, Chemours has averaged an EPS surprise of 0.57% and a revenue surprise of 0.02%.
Analyze the earnings history of Chemours using advanced sorting and filters.
The chart below shows Chemours's reported EPS compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-02-19 | $0.05 | $0.02 | 150.0 % |
| Q3 | 2025-11-06 | $0.20 | $0.24 | -16.7 % |
| Q2 | 2025-08-05 | $0.58 | $0.46 | 26.1 % |
| Q1 | 2025-05-06 | $0.13 | $0.20 | -35.0 % |
The chart below shows Chemours's reported revenue compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-02-19 | $1.30B | $1.33B | -2.18 % |
| Q3 | 2025-11-06 | $1.50B | $1.49B | 0.01 % |
| Q2 | 2025-08-05 | $1.62B | $1.57B | 2.99 % |
| Q1 | 2025-05-06 | $1.37B | $1.35B | 1.33 % |
Chemours (CC) is scheduled to report earnings on May 5, 2026. The last reported earnings were for reported on February 19, 2026 for Q4.
The Actual EPS was $0.05, which beat the estimate of $0.02.
The Actual Revenue was $1.30B, which missed the estimate of $1.33B.